Spinal Elements Holdings, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Spinal Elements Holdings, Inc. | SPEL - NASDAQ |
Postponed | $0.00 | $0.00 | Postponed | 10/15/2020 |
| Credit Suisse, Baird, Stifel | ||||||
Co-Manager(s): Truist Securities, BTIG, Siebert Williams Shank | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-09-23 Terms Added 2020-10-08 | ||||||
About Spinal Elements Holdings, Inc. (adapted from Spinal Elements Holdings, Inc. prospectus):
They are a medical device company focused on the design, development and commercialization of a comprehensive portfolio of systems, products and technologies for spine surgery procedures, with a strategic focus on minimally invasive surgery (“MISâ€) procedures.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a medical device company focused on the design, development and commercialization of a comprehensive portfolio of systems, products and technologies for spine surgery procedures, with a strategic focus on minimally invasive surgery (“MISâ€) procedures.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "SPEL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.